Literature DB >> 30232670

Serum NT-pro CNP levels in epileptic seizure, psychogenic non-epileptic seizure, and healthy subjects.

Mustafa Ceylan1, Ahmet Yalcin2, Omer Faruk Bayraktutan3, Esra Laloglu4.   

Abstract

PURPOSE: Epileptic seizure is the result of uncontrollable neural excitation in the brain. The C-type natriuretic peptide is a member of natriuretic peptide hormone family and is synthesized by brain and blood vessels in CNS. NT-pro CNP is an amino-terminal fragment of C-type natriuretic peptide and is more stable compared to its predecessor. In this study, we aimed to evaluate the role of NT-pro CNP in psychogenic non-epileptic seizures, epileptic seizures, and normal subjects.
METHODS: Thirty-three patients with epilepsy and 43 patients with psychogenic non-epileptic seizures were enrolled in this study. The control group consisted of 28 healthy subjects. Post-ictal serum levels of NT-pro CNP were acquired from all participants. Statistically significant differences between patient groups and controls regarding serum levels of NT-pro CNP were sought.
RESULTS: NT-pro CNP levels were significantly lower in the epilepsy group than the psychogenic non-epileptic seizure group and control group with no significant difference between the psychogenic non-epileptic seizure and control group (p < 0.05).
CONCLUSION: Post-ictal serum NT-pro CNP levels were lower in epileptic seizures compared to psychogenic non-epileptic seizures as well as healthy controls. We think that such a difference is associated with C-type natriuretic peptide-related neural mechanisms such as altered microcirculation, increased brain-blood barrier permeability, and synaptic stabilization.

Entities:  

Keywords:  Biomarker; Epilepsy; NT-pro CNP; Psychogenic non-epileptic seizure

Mesh:

Substances:

Year:  2018        PMID: 30232670     DOI: 10.1007/s10072-018-3562-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  27 in total

1.  Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid.

Authors:  Belinda J Schouten; Timothy C R Prickett; Ashley A Hooper; Gary J Hooper; Timothy G Yandle; A Mark Richards; Eric A Espiner
Journal:  Peptides       Date:  2011-01-22       Impact factor: 3.750

Review 2.  Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.

Authors:  Toshio Nishikimi; Koichiro Kuwahara; Kazuwa Nakao
Journal:  J Cardiol       Date:  2011-02-05       Impact factor: 3.159

3.  Video-EEG monitoring: safety and adverse events in 507 consecutive patients.

Authors:  Judith Dobesberger; Gerald Walser; Iris Unterberger; Klaus Seppi; Giorgi Kuchukhidze; Julia Larch; Gerhard Bauer; Thomas Bodner; Tina Falkenstetter; Martin Ortler; Gerhard Luef; Eugen Trinka
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

4.  Vascular effects of natriuretic peptides in healthy men.

Authors:  Marius Komarek; Alain Bernheim; Ruth Schindler; Renate Steden; Wolfgang Kiowski; Hans Peter Brunner-La Rocca
Journal:  J Cardiovasc Pharmacol Ther       Date:  2004-12       Impact factor: 2.457

Review 5.  Natriuretic peptide receptor-C signaling and regulation.

Authors:  Madhu B Anand-Srivastava
Journal:  Peptides       Date:  2005-04-08       Impact factor: 3.750

6.  Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.

Authors:  A J Stingo; A L Clavell; D M Heublein; C M Wei; M R Pittelkow; J C Burnett
Journal:  Am J Physiol       Date:  1992-10

Review 7.  Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review.

Authors:  N M G Bodde; J L Brooks; G A Baker; P A J M Boon; J G M Hendriksen; O G Mulder; A P Aldenkamp
Journal:  Seizure       Date:  2009-08-13       Impact factor: 3.184

8.  Paradoxical expressions of natriuretic peptide receptor-C and neutral endopeptidase account for C-type natriuretic peptide decline during the progression of experimental obstructive nephropathy.

Authors:  Peng Hu; Xue Qi Zhao; Jing Wang; Hai Bo Kong; Bo Hu; Ling Lu; Yuan Han Qin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2013-11-04       Impact factor: 1.636

9.  Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Chen-Chang Lee; Shang-Der Chen; Wen-Neng Chang; Cheng-Hsien Lu; Nai-Ching Chen; Alice Y W Chang; Samuel H H Chan; Yao-Chung Chuang
Journal:  BMC Neurol       Date:  2012-03-14       Impact factor: 2.474

Review 10.  Molecular biomarkers of epileptogenesis.

Authors:  Katarzyna Lukasiuk; Albert J Becker
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

View more
  3 in total

1.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

Review 2.  Psychogenic Non-Epileptic Seizures; a Narrative Review.

Authors:  Ameneh Jafari; Mostafa Rezaei Tavirani; Mohsen Parvareshi Hamrah; Sanaz Ahmadi Karvigh; Haniyeh Bashi Zadeh Fakhar
Journal:  Arch Acad Emerg Med       Date:  2020-01-20

3.  C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

Authors:  Cristina Perez-Ternero; Patrick N Pallier; Jordi L Tremoleda; Alessio Delogu; Cathy Fernandes; Adina T Michael-Titus; Adrian J Hobbs
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.